Literature DB >> 15259090

Alverine citrate induced acute hepatitis.

Mehmet Arhan1, Seyfettin Koklu, Aydln-S Koksal, Omer-F Yolcu, Senem Koruk, Irfan Koruk, Ertugrul Kayacetin.   

Abstract

Alverine citrate is a commonly used smooth muscle relaxant agent. A MEDLINE search on January 2004 revealed only 1 report implicating the hepatotoxicity of this agent. A 34-year-old woman was investigated because of the finding of elevated liver function tests on biochemical screening. Other etiologies of hepatitis were appropriately ruled out and elevated enzymes were ascribed to alverine citrate treatment. Although alverine citrate hepatotoxicity was related to an immune mechanism in the first case, several features such as absence of predictable dose-dependent toxicity of alverine citrate in a previous study and absence of hypersensitivity manifestations in our patient are suggestive of a metabolic type of idiosyncratic toxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15259090      PMCID: PMC4724969          DOI: 10.3748/wjg.v10.i15.2303

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  8 in total

Review 1.  Drug-induced liver disease.

Authors:  J H Lewis
Journal:  Med Clin North Am       Date:  2000-09       Impact factor: 5.456

2.  Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.

Authors:  George Ostapowicz; Robert J Fontana; Frank V Schiødt; Anne Larson; Timothy J Davern; Steven H B Han; Timothy M McCashland; A Obaid Shakil; J Eileen Hay; Linda Hynan; Jeffrey S Crippin; Andres T Blei; Grace Samuel; Joan Reisch; William M Lee
Journal:  Ann Intern Med       Date:  2002-12-17       Impact factor: 25.391

3.  [Severe erythema multiforme and hepatitis during treatment with trimebutine].

Authors:  Y Bacq; L Vaillant; C Monegier du Sorbier; E D Dorval; M Certin; E H Metman
Journal:  Gastroenterol Clin Biol       Date:  1989-05

Review 4.  [Digestive visceral sensitivity. Methods of study in humans and physiopathological implications].

Authors:  M Lémann; B Coffin; R Chollet; R Jian
Journal:  Gastroenterol Clin Biol       Date:  1995-03

5.  The effectiveness of simethicone in improving visibility during colonoscopy when given with a sodium phosphate solution: a double-bind randomized study.

Authors:  R H Sudduth; S DeAngelis; K E Sherman; P R McNally
Journal:  Gastrointest Endosc       Date:  1995-11       Impact factor: 9.427

6.  Mechanism of antifoaming action of simethicone.

Authors:  L Brecević; I Bosan-Kilibarda; F Strajnar
Journal:  J Appl Toxicol       Date:  1994 May-Jun       Impact factor: 3.446

7.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

8.  Acute hepatitis caused by alverine associated with anti-lamin A and C autoantibodies.

Authors:  D Malka; B N Pham; J C Courvalin; M Corbic; D Pessayre; S Erlinger
Journal:  J Hepatol       Date:  1997-08       Impact factor: 25.083

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.